Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Leptin, adiponectin levels, and thyroid hormones in normal and obese dogs

  • Lee, Sun-Hee (Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University) ;
  • Lim, Soo-Jung (Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University) ;
  • Park, Hyung-Jin (Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University) ;
  • Song, Kun-Ho (Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University)
  • Received : 2013.10.18
  • Accepted : 2014.06.02
  • Published : 2014.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

The present study compared leptin, adiponectin, and thyroid hormone concentrations in normal and obese dogs, and evaluated the association between leptin and adiponectin concentrations and thyroid function. The serum leptin, adiponectin, thyroid-stimulating hormone (TSH), total thyroxine (tT4), free thyroxine (fT4), triiodothyronine (T3), and cortisol concentrations were measured in 18 normal dogs (body condition score [BCS]: 4-5/9) and 16 obese dogs (BCS: 8-9/9). Leptin and T3 concentrations were higher in the obese group than the normal weight group (p < 0.01 and p < 0.05, respectively). In both groups, the T3 and leptin concentrations were correlated (r = 0.370, p < 0.05), as were the TSH and fT4 and adiponectin concentrations (r = -0.373, p < 0.05 and r = 0.369, p < 0.05, respectively). In the normal weight group, the TSH and fT4 concentrations were correlated with the adiponectin concentrations (r = -0.528, p < 0.05 and r = 0.482, p < 0.05, respectively). The results of the present study suggest that leptin and T3 concentrations are significantly higher in obese dogs than normal weight dogs, and the serum T3 and leptin concentrations are positively correlated.

Keywords

References

  1. Cettour-Rose P, Burger AG, Meier CA, Visser TJ, Rohner-Jeanrenaud F. Central stimulatory effect of leptin on T3 production is mediated by brown adipose tissue type II deiodinase. Am J Physiol Endocrinol Metab 2002, 283, E980-987. https://doi.org/10.1152/ajpendo.00196.2002
  2. Daminet S, Jeusette I, Duchateau L, Diez M, Van de Maele I, De Rick A. Evaluation of thyroid function in obese dogs and in dogs undergoing a weight loss protocol. J Vet Med A Physiol Pathol Clin Med 2003, 50, 213-218. https://doi.org/10.1046/j.1439-0442.2003.00534.x
  3. DiMascio L, Voermans C, Uqoezwa M, Duncan A, Lu D, Wu J, Sankar U, Reya T. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007, 178, 3511-3520. https://doi.org/10.4049/jimmunol.178.6.3511
  4. Eirmann LA, Freeman LM, Laflamme DP, Michel KE, Satyaraj E. Comparison of adipokine concentrations and markers of inflammation in obese versus lean dogs. Int J Appl Res Vet Med 2009, 7, 196-205.
  5. Fernández-Real JM, López-Bermejo A, Casamitjana R, Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 2003, 88, 2714-2718. https://doi.org/10.1210/jc.2002-021583
  6. Frank LA, Rohrbach BW, Bailey EM, West JR, Oliver JW. Steroid hormone concentration profiles in healthy intact and neutered dogs before and after cosyntropin administration. Domest Anim Endocrinol 2003, 24, 43-57. https://doi.org/10.1016/S0739-7240(02)00204-7
  7. German AJ, Hervera M, Hunter L, Holden SL, Morris PJ, Biourge V, Trayhurn P. Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol 2009, 37, 214-226. https://doi.org/10.1016/j.domaniend.2009.07.001
  8. Glass AR, Kushner J. Obesity, nutrition, and the thyroid. Curr Opin Endocrinol Diabetes Obes 1996, 6, 392-403.
  9. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004, 89, 2563-2568. https://doi.org/10.1210/jc.2004-0518
  10. Günzel-Apel AR, Seefeldt A, Eschricht FM, Urhausen C, Kramer S, Mischke R, Hoppen HO, Beyerbach M, Koivisto M, Dieleman SJ. Effects of gonadectomy on prolactin and LH secretion and the pituitary-thyroid axis in male dogs. Theriogenology 2009, 71, 746-753. https://doi.org/10.1016/j.theriogenology.2008.09.047
  11. Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007, 74, 11-18. https://doi.org/10.1016/j.cardiores.2006.10.009
  12. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50,1126-1133. https://doi.org/10.2337/diabetes.50.5.1126
  13. Ishioka K, Hosoya K, Kitagawa H, Shibata H, Honjoh T, Kimura K, Saito M. Plasma leptin concentration in dogs: effects of body condition score, age, gender and breeds. Res Vet Sci 2007, 82, 11-15. https://doi.org/10.1016/j.rvsc.2006.06.002
  14. Lacobellis G, Ribaudo MC, Zappaterreno A, Lannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 2005, 62, 487-491. https://doi.org/10.1111/j.1365-2265.2005.02247.x
  15. Laflamme DP, Kuhlman G, Lawler DF, Kealy RD, Schmidt DA. Obesity management in dogs. Vet Clin Nutr 1994, 1, 59-65.
  16. Lund EM, Armstrong PJ, Kirk CA, Kolar LM, Klausner JS. Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc 1999, 214,1336-1341.
  17. Mazaki-Tovi M, Feuermann Y, Segev G, Klement E, Yas-Natan E, Farkas A, Kol A, Shamay A. Increased serum leptin and insulin concentrations in canine hypothyroidism. Vet J 2010, 183, 109-114. https://doi.org/10.1016/j.tvjl.2008.08.017
  18. McGreevy PD, Thomson PC, Pride C, Fawcett A, Grassi T, Jones B. Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved. Vet Rec 2005, 156, 695-707. https://doi.org/10.1136/vr.156.22.695
  19. Miyawaki T, Masuzaki H, Ogawa Y, Hosoda K, Nishimura H, Azuma N, Sugawara A, Masuda I, Murata M, Matsuo T, Hayashi T, Inoue G, Yoshimasa Y, Nakao K. Clinical implications of leptin and its potential humoral regulators in long-term low-calorie diet therapy for obese humans. Eur J Clin Nutr 2002, 56, 593-600. https://doi.org/10.1038/sj.ejcn.1601363
  20. Nowak KW, Kaczmarek P, Mackowiak P, Ziolkowska A, Albertin G, Ginda WJ, Trejter M, Nussdorfer GG, Malendowicz LK. Rat thyroid gland expresses the long form of leptin receptors, and leptin stimulates the function of the gland in euthyroid non-fasted animals. Int J Mol Med 2002, 9, 31-34.
  21. Pillar TM, Seitz HJ. Thyroid hormone and gene expression in the regulation of mitochondrial respiratory function. Eur J Endocrinol 1997, 136, 231-239. https://doi.org/10.1530/eje.0.1360231
  22. Pinkney JH, Goodrick SJ, Katz J, Johnson AB, Lightman SL, Coppack SW, Mohamed-Ali V. Leptin and the pituitarythyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf) 1998, 49, 583-588. https://doi.org/10.1046/j.1365-2265.1998.00573.x
  23. Ritz P, Dumas JF, Salle A, Simard G, Malthiery Y, Rohmer V. Thyroid hormones and obesity. Ann Endocrinol (Paris) 2002, 63, 135-139.
  24. Roti E, Minelli R, Salvi M. Thyroid hormone metabolism in obesity. Int J Obes Relat Metab Disord 2000, 24 (Suppl 2), S113-115.
  25. Schaffler A, Scholmerich J, Salzberger B. Adipose tissue as an immunological organ: toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 2007, 28, 393-399. https://doi.org/10.1016/j.it.2007.07.003
  26. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270, 46-49.
  27. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007, 14, 189-206. https://doi.org/10.1677/ERC-06-0068